CSL Seqirus has announced that neffy adrenaline (epinephrine) nasal spray is now available.
The spray was TGA-approved earlier this year for use in emergency treatment of anaphylaxis in adults and children 15kg and aged four years and over (PD 19 Jan).
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Feb 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Feb 26